Desfesoterodine

Desfesoterodine is a pharmaceutical drug used in the treatment of overactive bladder. It is a prodrug of 5-hydroxymethyl tolterodine and is marketed under the trade name Toviaz.

Pharmacology

Desfesoterodine is a prodrug that is converted to its active form, 5-hydroxymethyl tolterodine, in the body. This active metabolite acts as a competitive antagonist at muscarinic receptors, which are involved in the contraction of the urinary bladder.

Clinical Use

Desfesoterodine is used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. It is marketed under the trade name Toviaz by Pfizer.

Side Effects

Common side effects of desfesoterodine include dry mouth, constipation, and urinary tract infection. Less common side effects include blurred vision, urinary retention, and dizziness.

See Also

• Tolterodine
• Overactive bladder
• Muscarinic antagonist

References

Desfesoterodine Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski